January 1, 2018Journal of Cancer31 citationsOpen Access

Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients

Key Points

Key points are not available for this paper at this time.

Abstract

rs9526814 may contribute to platinum resistance by influencing ATP7B gene expression and can be used as a potential biomarker to predict the sensitivity of platinum-based chemotherapy in NSCLC patients.

问 AI

Bookmark

View Full Paper

Cite This Study

Li et al. (Mon,) studied this question.

synapsesocial.com/papers/69fc58c6fb087793c078d8da https://doi.org/https://doi.org/10.7150/jca.26286

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1New Guidelines to Evaluate the Response to Treatment in Solid Tumors2000 · 15,756 citations
2Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial2015 · 16 citations
3Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines2001 · 69 citations
4Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer2002 · 5,002 citations
5Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin2003 · 88 citations

问 AI

Bookmark

View Full Paper